By Lawcer 
Searches for information on the prose hair lawsuit have grown in recent years as consumers look for clarity on product performance, billing practices, and legal recourse in the personalized beauty sector. As of May 2026, public court records do not show any active or recently resolved major class action lawsuit specifically alleging that Prose products cause hair loss or widespread physical harm. Verified searches of federal and state dockets have not identified such filings with case numbers, presiding judges, or formal settlements tied to product liability or efficacy claims.
Consumer complaints, however, have accumulated, primarily around subscription management, billing, and individual reports of hair or scalp changes. These issues have prompted discussions, pre-litigation inquiries by law firms, and regulatory self-oversight actions. One documented federal lawsuit exists from 2021 concerning website accessibility. This article examines the verifiable facts, the nature of consumer concerns, applicable legal frameworks, and practical implications for affected individuals.
Company Background and Subscription Model
Prose operates as a personalized hair care brand under PerSé Beauty Inc. (or related entities), with headquarters in Brooklyn, New York. The company, which launched around 2017, uses an online quiz to collect data on hair characteristics, lifestyle factors, location-specific elements such as water hardness, and stated goals. It then formulates and ships custom shampoos, conditioners, masks, and related products on a recurring subscription basis.
The business model relies on negative option or automatic renewal features common in direct-to-consumer beauty. Customers often begin with an initial order or trial-like experience, after which products ship and charges recur unless canceled. Prose promotes a “Prose Promise” or satisfaction guarantee, typically framed as a 30-day window for refunds or reformulations on first orders. The company has positioned itself with clean beauty attributes, including options that are vegan, sulfate-free, paraben-free, and phthalate-free, and it holds B Corp certification.
This subscription-heavy approach has drawn both praise for convenience and criticism when cancellation processes prove cumbersome or when customers report unexpected recurring charges.
The Documented Lawsuit: Website Accessibility (2021)
In February 2021, plaintiff Brian Fischler filed a complaint in federal court in New York against PerS Beauty, Inc. (case references appear as 1:21-CV-01563 in available summaries). The suit alleged that the Prose website, www.prose.com, failed to comply with Web Content Accessibility Guidelines (WCAG) 2.1 standards, thereby discriminating against blind or visually impaired individuals in violation of Title III of the Americans with Disabilities Act (ADA), 42 U.S.C. § 12181 et seq., as well as New York State and New York City human rights laws.
Specific allegations included missing or inadequate alternative text for images, unlabeled form fields and buttons, improper heading structures, duplicate IDs, and other technical barriers that could prevent screen reader users from navigating the site, completing the hair quiz, or managing accounts and purchases.
The complaint sought injunctive relief requiring the website to become fully accessible, declaratory relief, class certification (primarily under Federal Rule of Civil Procedure 23(b)(2) for injunctive classes), and related damages and attorney fees. Cases of this type frequently resolve through confidential settlement agreements in which the defendant agrees to conduct accessibility audits, remediate issues, and pay reasonable attorney fees, often without admitting liability. No public indications of ongoing active litigation in this specific matter appear in recent sources.
Website accessibility obligations under the ADA remain an active area of enforcement and private litigation for e-commerce companies. Courts have generally held that websites qualify as places of public accommodation when they facilitate access to goods and services offered to the public.
Consumer Complaints: Billing, Subscriptions, and Product Performance
Public records and consumer forums show two primary categories of complaints against Prose.
Billing and subscription issues represent the most frequent and consistent category. Reports to the Better Business Bureau and other platforms describe difficulties canceling subscriptions, unauthorized or unexpected charges, orders placed without clear affirmative consent, and challenges obtaining refunds outside narrow windows. Some consumers report that cancellation interfaces require multiple steps, include upsell prompts, or restart processes, creating friction. Others allege they believed they selected a one-time purchase but were enrolled in recurring billing.
These practices, when systemic, can raise questions under federal and state consumer protection statutes governing automatic renewals and negative option marketing.
Product-related reports include individual accounts of hair shedding, breakage, scalp irritation, dryness, or lack of noticeable improvement. Some users link timing of symptoms to product use. Dermatological explanations in public discussions sometimes reference temporary telogen effluvium triggered by scalp inflammation or sensitivity to certain botanical ingredients (such as essential oils), which can occur with many natural or “clean” formulations. Individual factors, including pre-existing conditions, concurrent styling practices, allergies, and usage patterns, complicate direct causation assessments. Prose products do not appear to contain DMDM hydantoin, a preservative that has featured in other hair care litigation.
No clinical studies or regulatory findings establishing a uniform causal link between Prose formulations and permanent hair loss have been identified in public sources. Personalized products inherently vary by customer inputs, which can make class-wide proof of defect or uniform misrepresentation more challenging.
Regulatory and Self-Regulatory Actions
In addition to court filings, Prose has been involved in self-regulatory proceedings before the National Advertising Division (NAD) of BBB National Programs. NAD has reviewed certain advertising claims, including representations about the volume or basis of customer reviews (for example, claims referencing large numbers of five-star reviews). In at least one instance, NAD recommended modifications or discontinuance of unqualified claims where the counting methodology (such as per-product or including reorders) was not adequately disclosed to consumers. Advertisers often agree to comply with NAD recommendations to avoid escalation.
The Federal Trade Commission (FTC) oversees advertising substantiation and negative option practices. The Restore Online Shoppers’ Confidence Act (ROSCA) requires clear and conspicuous disclosure of material terms for negative option offers, express informed consent, and simple cancellation mechanisms. While a proposed FTC “Click-to-Cancel” rule faced judicial challenges and was vacated in certain circuits, ROSCA remains in effect. State automatic renewal laws in jurisdictions such as California, New York, and others impose additional disclosure, notice, and cancellation requirements that can vary in stringency.
The FDA regulates cosmetics but generally does not require pre-market approval for most products. Structure or function claims (for example, those implying treatment or prevention of hair loss conditions) can reclassify a product as a drug, triggering different requirements. “Clean beauty” lacks a uniform legal definition, so related marketing claims require substantiation under FTC standards.
Potential Legal Theories and Litigation Considerations
Discussions of the prose hair lawsuit often reference possible claims under consumer protection statutes. For billing practices, potential theories include violations of state unfair and deceptive acts and practices (UDAP) laws, breach of contract (particularly regarding advertised guarantees or cancellation policies), and unjust enrichment. Class actions in the subscription space have succeeded in other cases when plaintiffs demonstrate common policies or website flows affecting a large group, satisfying Rule 23 requirements of numerosity, commonality, typicality, and adequacy of representation. Predominance of common questions can be easier to establish for systemic billing issues than for individualized product reaction claims.
For product performance or safety allegations, plaintiffs might pursue negligence, strict products liability, breach of express or implied warranties, or misrepresentation. However, certification of a class often faces hurdles when reactions vary significantly by individual biology, usage, and other factors. Courts require rigorous analysis of whether common proof can establish liability and damages across the proposed class.
Pre-litigation activity, including law firm intake forms and monitoring by class action aggregator sites, does not equate to filed or certified litigation. Speculative online documents lacking docket citations should be viewed cautiously.
Practical Steps for Consumers
Individuals experiencing billing difficulties should review account settings and transaction history, attempt cancellation through official channels while documenting every step with screenshots and timestamps, and contact customer support in writing. Credit card disputes or chargebacks may be available within issuer time limits, though success depends on specific circumstances and card network rules.
For health or scalp concerns, discontinue use and consult a board-certified dermatologist. Documentation of symptoms, timing relative to product use, and lot numbers can be useful. Adverse event reports can be submitted to the FDA through MedWatch. Complaints may also be filed with the FTC at ReportFraud.ftc.gov, state attorneys general, and the BBB.
Statutes of limitations vary by claim type and jurisdiction; prompt action preserves options. Individual circumstances differ, and not every complaint gives rise to a viable legal claim.
Broader Context and Industry Implications
The personalized beauty and subscription commerce sectors continue to face scrutiny over transparency in marketing, ease of cancellation, and substantiation of efficacy claims. High-profile cases involving other brands have highlighted risks associated with automatic renewal practices and certain ingredients. Companies operating in this space must navigate overlapping federal, state, and self-regulatory expectations.
For consumers, the growth of direct-to-consumer models offers customization but also places greater responsibility on individuals to understand terms, monitor accounts, and act quickly on issues. Public records and regulatory actions provide the most reliable indicators of legal developments; social media amplification can sometimes outpace verified court activity.
Conclusion
The prose hair lawsuit conversation reflects real consumer experiences with subscription mechanics and variable product results in a personalized hair care context. While no major product liability class action appears in current public court records, documented complaints and the 2021 accessibility case underscore ongoing legal and compliance considerations for the company and valuable lessons for the industry. Billing and cancellation practices present clearer pathways for potential collective claims under existing consumer protection statutes than individualized efficacy or safety allegations.
You May Also Like: Apothekary Lawsuit Overview: Allegations and Legal Response